Abiopharma

News list

(10% Negative) HOMOLOGY MEDICINES, INC. (FIXX) Announces Clinical Trial Timeline Adjustment

Full text

News bot Oct. 2, 2025, 7 a.m.
📋 HOMOLOGY MEDICINES, INC. (FIXX) - Clinical Trial Update

Filing Date: 2022-06-13

Accepted: 2022-06-13 08:20:32

Event Type: Clinical Trial Update
Event Details:
Homology Medicines Inc (was merged with Q32 Bio Inc. (NASDAQ: QTTB) n 25/03/2024) (FIXX) Announces Clinical Trial Update Homology Medicines Inc (was merged with Q32 Bio Inc. (NASDAQ: QTTB) n 25/03/2024) (FIXX) provided an update on its clinical development programs. Clinical Development Highlights:
Update Type: Trial Timeline Adjustment
Primary Factors: Pandemic-Related Challenges, Regulatory Process
Collaboration: Registrant
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: Homology Medicines Inc (was merged with Q32 Bio Inc. (NASDAQ: QTTB) n 25/03/2024)
- CIK: 0001661998
- Ticker Symbol: FIXX
- Period End Date: 2022-06-13
- Document Type: 8-K